Abbvie Inc (NYSE:ABBV)

88.57
Delayed Data
As of Sep 22
 -0.52 / -0.58%
Today’s Change
62.55
Today|||52-Week Range
101.28
+0.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$159.0B

Company Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Contact Information

AbbVie, Inc.
1 North Waukegan Road
North Chicago Illinois 60064-6400
P:(847) 932-7900
Investor Relations:
(847) 935-2211

Employees

Shareholders

Mutual fund holders36.30%
Other institutional34.38%
Individual stakeholders0.12%

Top Executives

Richard A. GonzalezChairman & Chief Executive Officer
Michael E. SeverinoVice Chairman & President
Azita Saleki-GerhardtExecutive Vice President-Operations
Robert A. MichaelChief Financial Officer & Executive Vice President
Thomas J. HudsonChief Scientific Officer, Senior VP-R&D